Title | BIO302 Exam 1 Study Guide |
---|---|
Author | Ro Mo |
Course | Cancer: Mother of All Diseases |
Institution | Arizona State University |
Pages | 6 |
File Size | 159.2 KB |
File Type | |
Total Downloads | 27 |
Total Views | 156 |
Download BIO302 Exam 1 Study Guide PDF
• • •
• • • • • • • • • • • • • • • • • • • • •
TRUE: Compared to other major diseases, cancer death rates have changed little over the past 60 years. TRUE: More and more people are getting cancer because we live longer now and cancer increases with age. TRUE: Cancer is a global problem. o More than 60% of the world’s new cancer cases occur in Africa, Asia, and Central/South America TRUE: In 2003, despite increasing population size and lifespan, the American Cancer Society announced the total number of deaths from cancer in the U.S. TRUE: Recent statistics show decreases in mortality rates for some cancers (lung, breast, colon, prostate) TRUE: Cancer death rates have fallen 25% since 1991. TRUE: A single nucleotide polymorphism (SNP) is found in more than 1% of the population, while a mutation is found in less than 1% of the population TRUE: Mutations can be repaired or cells can be prevented from mutating from replicating by mutation control. TRUE: Mutations happen all the time in human cells but are normally repaired or eliminated to maintain order and stability within the organism. TRUE: There are multiple highly evolved cellular mechanisms that exist to protect against changes in DNA (mutations) that occur as part of life. TRUE: In normal cells, if DNA damage can’t be repaired, programmed death of cells or immune destruction of cells occurs. TRUE: The development of cancer requires the loss, malfunction, or overriding of normal mutation control mechanisms. TRUE: The loss of control seen in cancer cells is itself caused by mutation in control mechanisms. TRUE: All processes involved in the development of cancer are integrally linked to fundamental mammalian biology and the evolution of biological life itself. TRUE: Elimination of cancer would require elimination of mutation. TRUE: Mutation is integral to normal biology and cannot be eliminated. TRUE: Cancer can never be eliminated as a disease process. TRUE: We are evolved to be susceptible to cancer. TRUE: Genomic “instability” is fundamental to cancer’s ability to acquire new traits and pass them on to progeny TRUE: Genomic instability leads to accumulation of key (“driver”) mutations required for cancer progression. TRUE: Genes that drive cell division are always “on” or gain function. TRUE: Not all tumors are cancer but all tumors are abnormal and require diagnosis TRUE: Most cancers come from dysplasias, not benign neoplasms TRUE: Dysplastic cells typically grow in masses and form benign tumors
• • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
TRUE: Expansion of dysplastic cells occurs within flat surface, has ill-defined borders, and cannot be identified with the naked eye TRUE: Biopsies and cytology with microscopic examination is required for diagnosis TRUE: Carcinoma is by far the most common human malignancy TRUE: Carcinoma in situ never metastasizes TRUE: Not all carcinogens are mutagens, but all mutagens are carcinogens TRUE: Most cancer-initiating mutations are acquired, not inherited TRUE: Somatic mutations cannot be inherited, while germline mutations can be inherited. TRUE: Cancer is primarily an environmental disease. TRUE: Laboratory studies in humans that are analogous to those in non-human systems are unethical. FALSE: Some carcinogens have been found to always cause cancer, under all circumstances. TRUE: There are some substances in vegetables and fruits that may help protect against cancer, especially in cruciferous vegetables! TRUE: Viruses associated with human cancers include: Hep B/C and HIV. TRUE: Most cancer can be prevented through behavior change. TRUE: A causal factor is a determining element of a disease. TRUE: Detection by screening decreases the time to diagnosis and treatment. TRUE: Sensitivity does not take false positives into account and specificity does not take false negatives into account. TRUE: All causal factors are risk factors for cancer, but not all risk factors are causal TRUE: Cancers generally take years to develop following carcinogen exposure. TRUE: Some of the agents that are used to treat cancer also cause cancer. TRUE: The right therapy and management are dependent on the right diagnosis and assessment. TRUE: For most cancers, there are no effective screening tests. TRUE: The rarer the disease, the more likely false positives are to be. TRUE: Our most effective screening tools are the Pap smear and colonoscopy TRUE: PSA-based screening is Grade D, meaning it is highly discouraged. TRUE: Physician education is highly necessary because the large number of uninformed patients is related to the large number of uniformed clinicians. TRUE: Mortality rates are the only way to judge cancer screening accurately. TRUE: The two types of bias that mislead physicians into thinking screening saves lives are lead time bias and over-diagnosis bias TRUE: The goal of screening is to detect disease early and treat before cancer has progressed. TRUE: Effective screening is defined by a decrease mortality from the disease in the screened versus unscreened population TRUE: The benefit-to-harm ratio of screening tests depends on false negative and false positive rates. TRUE: The predictive value of a screening test depends on the prevalence of the disease.
• • • • • • • • •
TRUE: Cancer site implies survival differences. TRUE: The less resemblance to normal morphology, the higher the grade. TRUE: High grade tumors grow and spread more aggressively and are less responsive to therapy than low grade tumors. TRUE: Grade of cancer is based on degree of differentiation of cancer cells. TRUE: Stage of cancer is based on how far cancer has progressed at diagnosis based on extent of local tumor and spread of disease (TNM system) TRUE: The greater the spread, the higher the stage. TRUE: Survival correlates with stage (highest stage being incurable) TRUE: Stage is a more powerful predictor of outcome than grade and is more clinically useful in classifying patients. TRUE: The higher the tumor grade and stage, the lower the probability of survival
• • • • • • • •
• • •
•
•
The mortality rate is the cancer deaths per 100,000 population per year The biggest factor in improved prevention, detection, and treatment is the decline in smoking Natural evolution is the mutation and selection that favors “fitness” with respect to competition, adaptation, and survival within a physical environment Cancer evolution is the mutation and selection that favors “fitness” with respect to competition, adaptation, and survival within the body’s biological environment A permanent change in the nucleotide sequence of DNA that can be passed on to daughter cells with mitosis is called a mutation A specific type of mutation that is considered to be in the realm of normal human variation is a single nucleotide polymorphism A SNP is defined by convention according to frequency The acquired characteristics cancers have in common include: o Uncontrolled cell division o Invasion and destruction of normal tissues o Metastasize: Ability to travel to and colonize other parts of the body Hallmarks of cancer include abnormal form and function. Some examples of abnormal form include: abnormal cytology and abnormal tissue (histopathological) morphology Some examples of abnormal function include: o Resistance to cell death o Sustaining of proliferative signaling o Evasion of growth suppression o Limitless replicative potential o Ability to invade and metastasize o Induction of new blood supply (angiogenesis) “Cancer” is the term that refers to a group of diseases in which abnormal cells: o Divide without control o Invade (and destroy) other tissues without control o Metastasize (travel to other parts of the body through the blood and lymph) The process of a normal cell turning cancerous is called carcinogenesis
• • • •
• • • • • •
•
• • • • • • • • • • • • • • •
Carcinogenesis always requires mutation in the genome of the cell (initiation) AND proliferation (growth) of the genetically altered cell (promotion) Additional mutations accumulate in a multistep process with growth over time (progression) A mass of abnormal (mutated) cells is called a neoplasm Normal cell growth includes hypertrophy (increase in cell size) and hyperplasia (increase in cell number), while abnormal cell growth includes dysplasia (precancer; does not form mass/tumor) and neoplasia (benign or malignant) Dysplasia and neoplasia are irreversible Initiators cause mutation in one cell capable of dividing Promoters promote clonal expansion (proliferation) of initiated (mutated) cells, but don’t affect normal cells Progressors cause additional mutations that confer additional growth-aggressive changes Low grade dysplasia occurs when initiated cell clones gain additional proliferative advantage and begin to change their morphology High grade dysplasia (carcinoma in situ) occurs when more mutations happen within proliferative cell line lead to development of pre-invasive cancer; it is high risk for progression to cancer and must be treated!! Invasive carcinoma (malignant neoplasm) invades through basal lamina is now classified as malignant and considered capable of metastasis. This is the beginning of epithelial-mesenchymal transformation Cancer cells with migratory and invasive properties break through walls of lymphatics or blood vessels in metastasis Carcinoma is cancer arising from epithelial cells (covering/lining cells) Keratin “pearl” is a concentric collection of cornified squamous cells seen in carcinoma Sarcoma is cancer arising from connective tissue cells Lymphoma is cancer that arises from immune system cell precursors in bone marrow or lymph nodes Systemic Leukemia arises from blood forming cells in bone marrow Melanoma arise from pigment-producing cells in epithelia Acute lymphocytic leukemia happens when leukemic cells have replaced normal blood forming cells Anaplastic refers to cancers that are unclassifiable because they are so undifferentiated Neoplasias are abnormal tissue growths characterized by mutation, abnormal cell appearance, abnormal tissue architecture, and growth advantage Neoplasms are classified by their site of origin and their predominant cell type (differentiation pattern) Carcinogens are agents that cause cancer Mutagens are agents that alter DNA Empirical science includes information gained by experience, observation, or experiment observation, induction, deduction, testing Causal factors are those that are mutation-causing risk factors
•
•
• • • • •
•
•
• • •
Causal inference is the process of deriving cause-and-effect conclusions by reasoning from knowledge and factual evidence reduction in risk with removal of exposure, consistency of association, biological plausibility Risk factors are characteristics, conditions, or behaviors that increase probability of a cancer; vary in degree of risk imposed and may/may not be a causal factor o Some can be treated: chronic inflammation, viral infections, bacterial infections, diabetes, etc o Tobacco and diet/obesity are biggest causes of cancer Obesity is associated with substantial metabolic and endocrine abnormalities and has been linked to 13 different cancers Screening for cancer involves testing people without symptoms and testing defined populations (usually those at risk) A test’s ability to correctly identify those WITH the disease is test sensitivity A test’s ability to correctly identify those WITHOUT the disease is test specificity Test performance is depicted by the RoC curve, where the area under curve (AUC) represents perfection, measuring the diagnostic accuracy across spectrum of test values The probability that an individual is affected by the disease when the test result is positive (counting false positives) is the positive predictive value o = The probability that an individual is not affected by the disease when the test result is negative (counting false negative) is the negative predictive value o = Diagnosis is the identification of a disease in an individual through process of evaluation and elimination Symptoms include patient’s perceptions, while signs are examiner’s observations TNM Staging System refers to tumor, nodes, and metastases progression.
!"" • • • • • • • • • •
Imhotep: documents first reported case of cancer Hippocrates: uses word carcinoma to describe tumors and recognizes benign versus malignant Galen: Uses word “oncos” meaning “mass” to describe tumors Celsus: translates word crab into Latin as “cancer” Sir Percivall Pott: first demonstrated cancer can be caused by environment Rudolf Virchow: discovered cancer is made up of otherwise normal cells Theodor Boveri: suggested that cancer comes from single somatic cell with chromosomal alterations causing uncontrolled growth Thomas Hunt Morgan: demonstrated genes are carried on chromosomes, validating Boveri’s hypothesis Paul Ehrlich: coined term “chemotherapy” and developed concept of using chemicals to treat disease Sir Austin B. Hill and Sir Richard Doll: Linked smoking and lung cancer
•
• • • • • • • • • • • • • •
William S. Halsted: Developed “radical mastectomy” procedure with the notion that the wider the excision, the greater the chance of preventing metastasis and curing disease Claudius Regaud: Showed normal tissue sparing effects by reducing dose rates and delivering doses at spaced intervals could stop rapidly growing cells like cancer George Papanicolaou: Developed Pap test for early detection of cervical cancer Sidney Farber: Achieved first remission of cancer using drugs; father of chemotherapy Peter Nowell and David Hungerford: reported recurrent chromosomal translocation (Philadelphia chromosome in CML cells) Henry S. Kaplan: established importance of clinical staging and used radiation therapy to successfully treat Hodgkin’s disease Vincent T. Devita: developed first combination therapy to produce a high proportion of complete remission and cure (MOPP) Bernard Fisher: lumpectomy just as effective as radical mastectomy for breast cancer Harald Zur Hauzen: Discovered causal link between HPV (Human Papilloma Virus) and cervical cancer, leading to development of a vaccine Michael Bishop and Harold Varmus: discovered viral genes with ability to cause cancer are derived from mammalian genome (cancer causation is innate) Weinberg, Wigler, and Barbacid: simultaneously discovered first human oncogene (RAS) Webster Cavenee: first validation of presence of tumor suppressor gene in humans Brian Druker: discovered CML is caused by a single driver mutation and its oncoprotein; able to provide a cure to formerly incurable disease Dennis Slamon: identified amplified oncogene in breast cancer Gordon Freeman: discover PD-L1 is expressed by cancer cells, allowing them to evade immune destruction
#$% &'$ • • • •
• •
National Cancer Institute: Federal government’s primary agency for cancer research and training National Cancer Act: Amended Public Health Service Act to strength NCI The Cancer Genome Atlas: Goal to define and catalog all genomic defects in cancers International Agency for Research on Cancer: evaluates risk of carcinogenicity with Group 1 being worst and Group 4 being decent (lists those found not to be carcinogens) The Report on Carcinogens (RoC) lists two groups, those known to be human carcinogens and those reasonably anticipated to be human carcinogens U.S. Preventative Services Task Force gives evaluations and recommendations (grades) regarding cancer treatments and practices ...